MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2024 International Congress

    MDS Clinical Supportive Criteria for Parkinson’s Disease are Associated with α-Synuclein Seed Amplification Assay Status

    D. Belete, E. Mitchell, N. Donkor, A. Noyce, C. Simonet (London, United Kingdom)

    Objective: To assess the association between α-synuclein seed amplification assay (α-synuclein SAA) status with the supportive criteria of the MDS Clinical Diagnostic Criteria for Parkinson’s…
  • 2024 International Congress

    Pallidotomy as a Therapeutic Option for Patients with Advanced Parkinson’s Disease: Case Study

    R. Pessoa, L. Cidral, E. de Souza, M. Marchiori (Curitiba, Brazil)

    Objective: The aim of this research is to assess unilateral pallidotomy as a surgical alternative for Parkinson's Disease (PD), emphasizing improvements in contralateral motor symptoms…
  • 2024 International Congress

    Mitigating The Impact Of Covid-19 On Parkinson’s Disease: Insights From Vaccination Strategies

    J. Salimjonov, KH. Khalimova, N. Rashidova, R. Matmurodov (Tashkent, Uzbekistan)

    Objective: This study aimed to investigate the impact of COVID-19 infection on patients with Parkinson's disease (PD), comparing those who received COVID-19 vaccines and those…
  • 2024 International Congress

    Assessment of cognitive impairment in Parkinson’s disease in under-represented ethnic groups-The London-Dhaka Parkinson’s Cognitive Study

    T. Zannat, KC. Dey, A. Zirra, A. Haque, E. Camboe, D. Mair, T. Haque, S. Waters, CR. Marshall, RS. Weil, S. Ali, N. Mukadam, AJ. Noyce, A. Habib (Dhaka, Bangladesh)

    Objective: The aim of this study is to evaluate the prevalence of CI in a diverse group of PwP from East London, UK and Dhaka,…
  • 2024 International Congress

    To develop and study the efficacy of Telephonic Psychotherapy on the Global Neuropsychological functioning of PD Patients: An RCT

    R. Hazrati, R. Makkar, A. Nehra (New Delhi, India)

    Objective: A single blinded RCT was conducted to develop and test the efficacy of a telephonic psychotherapy on PD Patients. PD patients bound by movement…
  • 2024 International Congress

    Blood Pressure Profile of PD-MCI and PDD in Parkinson’s Disease Patients at Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia

    A. Al Jody, A. Tiksnadi, D. Tunjungsari (Jakarta, Indonesia)

    Objective: This study aims to explore the BP profile in both PD-MCI and PDD Background: Blood pressure (BP) abnormality is often correlated with cognitive impairment. However,…
  • 2024 International Congress

    Comparative Effectiveness of Behavioral or Drug Therapy for Overactive Bladder Symptoms in Parkinson Disease

    C. Vaughan, J. Morley, J. Lehosit, G. Mcgwin, L. Muirhead, A. Khakharia, T. Johnson Ii, M. Evatt, T. Sergent, K. Burgio, A. Markland (Atlanta, USA)

    Objective: Assess the comparative effectiveness of behavioral or solifenacin drug therapy over 12 weeks for overactive bladder (OAB) symptoms according to the International Consultation on…
  • 2024 International Congress

    SCN9A Gene Variant in a PD Case with Refractory Dysesthesias

    J. Park, B. Barton (Chicago, USA)

    Objective: Describe an unusual case of severe pain syndrome associated with a predisposing genetic mutation, and review literature on causes of enhanced pain in PD.…
  • 2024 International Congress

    Clinical and Neuroimaging Biomarker Predictors of Autonomic Dysfunction in Parkinson’s Disease: A Study Using PPMI Data

    A. Oliveira Franco, M. Machado Schlindwein, J. Rossi Catao, D. Teixeira-Dos-Santos, A. Bieger, T. Hugentobler Schlickmann, L. Angi Souza, C. Mattjie, F. Suzuki, G. Magalhães Pereira, L. Silveira Kupssinskü, L. Vinícius Moura, R. Ravazio, S. Duarte Pinto, M. de Bastiani, R. Barros, E. Zimmer, A. Schumacher Schuh (Porto Alegre, Brazil)

    Objective: To evaluate whether clinical and neuroimaging baseline markers predict the onset of significant dysautonomia over five years in individuals with idiopathic, de novo Parkinson's…
  • 2024 International Congress

    Beyond constipation: gastrointestinal phenomena in Parkinson’s disease

    MA. Silveira, H. Dourado, G. Procópio, M. Sampaio, IJ. Oliveira, L. Almeida, G. Valença (Salvador, Brazil)

    Objective: To describe the prevalence of gastrointestinal manifestations in patients with Parkinson's disease in a Brazilian movement disorders outpatient clinic and evaluate their associated factors…
  • « Previous Page
  • 1
  • …
  • 178
  • 179
  • 180
  • 181
  • 182
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley